Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could these new drops soothe dry eyes?

NCT ID NCT06444516

Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new eye drop formula in 188 adults with mild to moderate dry eye disease. Participants used the drops for 30 days and reported how much their symptoms bothered them. The goal was to see if the drops safely improve comfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ocular lubricant (eye drops)
What this could lead to
If it works, this could provide a new over-the-counter option to ease dry eye symptoms.
What could go wrong
This is a small, single-arm study with no placebo group, so results may not prove the drops are better than existing products. The trial is already completed, but the findings are not yet published.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

188 people

The number who actually took part.

Started

Sep 2024

Finished

Feb 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Willing and able to understand and sign an approved informed consent form. * Exhibit symptoms of dry eye at the Screening visit. * Best Corrected Visual Acuity equal to or better than 20/80 Snellen in each eye at the Screening visit. * Willing to discontinue use of all artificial tear supplements and use only the study product as directed starting at Visit 2/Day 1. * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Pregnant, breastfeeding, or planning to become pregnant during the study. * Ocular abnormalities that could adversely affect the safety or efficacy outcome. * Uncontrolled active systemic diseases. * Use of systemic medications known to cause dry eye. * Other protocol-defined exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye disease

Contacts and locations

Locations

  • Clarke Eyecare Center

    Wichita Falls, Texas, 76308, United States

  • Franklin Park Eye Center, PC

    Franklin Park, Illinois, 60131, United States

  • Kannarr Eye Care, LLC

    Pittsburg, Kansas, 66762, United States

  • Kindred Optics at Maitland Vision Center

    Maitland, Florida, 32751, United States

  • Optometry Group, PLLC

    Memphis, Tennessee, 38111, United States

  • ProCare Vision Center

    Granville, Ohio, 43023, United States

  • SUNY College of Optometry Clinical Vision Research Center

    New York, New York, 10036, United States

  • Vision Health Institute

    Orlando, Florida, 32803, United States

  • Wyomissing Optometric Center

    Wyomissing, Pennsylvania, 19610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.